The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.
You don’t have to miss the innovation because you missed the conference. In this ASHG25 workshop replay, we unveil a new automated microarray workflow that enables sample-to-report in ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...
SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...
Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
[Image from Micron Biomedical website] Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million. J2 Ventures and the Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results